Advertisement

Rheumatische Syndrome bei verschiedenen nichtrheumatischen Erkrankungen

Chapter
  • 3.1k Downloads

Auszug

Bekanntlich können rheumatische Erkrankungen zu Affektionen der inneren Organe führen, die gelegentlich sogar die Symptomatologie dominieren, also Leitsymptome sind, so dass erst durch die internistische Untersuchung das zugrunde liegende rheumatische Leiden nachzuweisen ist. Andererseits kann aber auch der rheumatische Schmerz und die rheumatische Entzündung durch interne Erkrankungen ausgelöst werden. Dies ist verständlich, wenn man die multifaktorielle Genese rheumatischer Krankheitszustände berücksichtigt, wie sie schematisch bei Arthralgien und Arthritiden in ⊡ Abb. 2.2 dargestellt ist. Darüber hinaus ist zu beachten, dass erst Komplikationen rheumatischer Erkrankungen (z. B. Amyloidose) oder unerwünschte Wirkungen der bei einer rheumatischen Erkrankung verordneten Medikamente (z. B. Steroidosteoporose, Magen-Darm-Ulzera bei Gabe nichtsteroidaler Antiphlogistika) zu Symptomen an verschiedenen Organen führen können. Schließlich können auch 2 oder mehr voneinander unabhängige Erkrankungen vorliegen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur Literatur zu 9.1.2

  1. Kaplan G (1996) Rheumatische Manifestationen bei HIV-Infektionen. Rheumatol Europa 25:134–136Google Scholar
  2. Lhote F (2004) Systemic vasculitis during parasitosis. Press Med 33:1389–1401Google Scholar
  3. Oyoo O, Espinoza LR (2005) Infection-related vasculitis. Curr Rheumatol Rep 7:281–287PubMedGoogle Scholar
  4. Rubbert A (2002) Arthritiden bei HIV-Infektionen. Akt Rheumatol 27:133–137Google Scholar
  5. Somer T, Finegold SM (1995) Vasculitides associated with infections, immunisation and antimicrobial drugs. Clin Infect Dis 20:1010–1036PubMedGoogle Scholar
  6. Zeller V, Lortholary F (2004) Vasculitis secondary to fungal infections. Press Med 33:1385–1388Google Scholar

Literatur zu 9.1.3

  1. Bannwarth B (2007) Drug-induced musculoskeletal disorders. Drug Safety 30:27–46PubMedGoogle Scholar
  2. Brenner J, Solitar BM, Golden BD (2000) Rheumatic manifestations of current pharmacopeia. Curr Rheumatol Rep 2:151–155PubMedGoogle Scholar
  3. Brogan BL, Olsen NJ (2003) Drug-induced rheumatic syndromes. Curr Opin Rheumatol 15:76–80PubMedGoogle Scholar
  4. Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, Sierra A, Hershman DL (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25:3877–3883PubMedGoogle Scholar
  5. Cuende E, Fraguas J, Peña JE, Peña F, García JC, Gonález M (1999) Beekeeper’ arthropathy. J Rheumatol 26:2684–2690PubMedGoogle Scholar
  6. Geier DA, Geier MR (2002) A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol 20:767–771PubMedGoogle Scholar
  7. Geier MR, Geier DA (2004) A case-series of adverse events, positive rechallenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 22:749–755PubMedGoogle Scholar
  8. Gelpi E, de la Paz MP, Terracini B, Abaitua I, de la Cámara AG, Kilbourne EM, Lahoz C, Nemery B, Philen RM, Soldevilla L, Tarkowski S; WHO/CISAT Scientific Committee for the Toxic Oil Syndrome. Centro de Investigación para el Síndrome del Aceite Tóxico (2002) The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. Environ Health Perspect 110:457–464PubMedGoogle Scholar
  9. Grasland A, Vinceneux P (1999) Rheumatische Manifestationen von Impfungen. Rheumatol Europa 28:25–27Google Scholar
  10. Gronseth GS (2005) Gulf war syndrome: a toxic exposure? A systematic review. Neurol Clin 23:523–540PubMedGoogle Scholar
  11. Kim MJ, Ye YM, Park HS, Suh CH (2006) Chemotherapy-related arthropathy. J Rheumatol 33:1364–1368PubMedGoogle Scholar
  12. Hamilton ME (1986) Eosinophilic fasciitis associated with α-tryptophan. Ann Rheum Dis 50:55–56Google Scholar
  13. Ioannou Y, Isenberg DA (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43:1431–1442PubMedGoogle Scholar
  14. Minden K, Niewerth M, Brote M, Singendonk W, Haas JP (2007) Immunization in children and adolescents with rheumatic diseases. Z Rheumatol 66:111–120PubMedGoogle Scholar
  15. Older SA, Battafarano DF, Enzenauer RJ, Krieg AM (2000) Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 29:131–139Google Scholar
  16. Olsen NJ (2004) Drug-induced autoimmunity. Baillieres Best Pract Res Clin Rheumatol 18:667–688Google Scholar
  17. Panush RS, Stroud RM, Webster EM (1991) Food-induced (allergic) arthritis. Arthritis Rheum 29:220–226Google Scholar
  18. Volpe A, Marchetta A, Caramaschi P, Biasi D, Bambara LM, Arcaro G (2008) Hydroxychloroquine-induced DRESS syndrome. Clin Rheumatol 27:537–539PubMedGoogle Scholar
  19. Wagner P, Schulte D (1993) TX-Arthopathie. Rheumatologische Manifestationen bei Patienten nach Herz-, Lungen-und Knochenmarktransplantationen. Med Welt 44:509–515Google Scholar

Literatur zu 9.1.4

  1. Asherson RA, Francès C, Iaccarino L, Khamashta MA, Malacarne F, Piette JC, Tincani A, Doria A (2006) The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol 24(1 Suppl 40):S46–51Google Scholar
  2. Cardoso R, Goncalo M, Tellechea O, Maia R, Borges C, Silva JA, Figueiredo A (2007) Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren’s syndrome. Int J Dermatol 46:431–434PubMedGoogle Scholar
  3. Cuellar ML (2002) Drug-induced vasculitis. Curr Rheumatol Rep 4:55–59PubMedGoogle Scholar
  4. El Mahou S, Sailler L, Madaule S, Arlet P (2006) RACAND syndrome as a paraneoplastic syndrome? J Clin Rheumatol 12:104–105Google Scholar
  5. Grau R (2002) Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep 4:83–89PubMedGoogle Scholar
  6. Heidrich H (1993) Das Raynaud-Syndrom. Dtsch Ärztebl 90:3296–3304Google Scholar
  7. Lie JT (1994) Nomenclature and classification of vasculitis: Plus ça chance, c’est la même chose. Arthritis Rheum 37:181–186PubMedGoogle Scholar
  8. Lie JT (1996) Vasculitis associated with infections agents. Curr Opin Rheum 8:26–29Google Scholar
  9. Molloy ES, Langford CA (2008) Vasculitis mimics. Curr Opin Rheum 20:29–34Google Scholar
  10. Oh YB, Jun JB, Kim CK, Lee CW, Park CK, Kim TY, Yoo DH, Kim SY (2000) Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 19:381–384PubMedGoogle Scholar
  11. Sale A, Stone JH (2005) Classification and diagnostic criteria in systemic vasculitis. Baillieres Best Pract Res Clin Rheumatol 19:209–221Google Scholar
  12. Schnabel A, Gross WL (1996) Raynaud Syndrom. Internist 37:867–879PubMedGoogle Scholar
  13. Scott DGI, Watts RA (1994) Classification and epidemiology of systemic vasculitis. Br J Rheumatol 33:897–900PubMedGoogle Scholar
  14. Somer T, Finegold SM (1995) Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 20:1010–1016PubMedGoogle Scholar
  15. Wiik A (2008) Drug-induced vasculitis. Curr Opin Rheum 20:35–39Google Scholar

Literatur zu 9.1.5

  1. Announ N, Guerne PA (2007) Diagnose und Therapie der of Kalziumpyrophosphatkristal-induzierten Arthropathie. Z Rheumatol 66: 573–578PubMedGoogle Scholar
  2. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55–60PubMedGoogle Scholar
  3. Bartner R, Will M, Conrad J, Engelhardt A, Schwarz-Eywill M (2005) Kupfermangel als seltene Ursache von Panzytopenie, Arthralgien und Gangstörungen. Med Klin 100:497–501Google Scholar
  4. Benhamou CL, Halimi D, Luton JP, Chevrot A, Amor B, Bricaire H (1984) Manifestations ostéoarticulaires au cours des insuffisances surrenales. Rev Rhum 51:69–74PubMedGoogle Scholar
  5. Buxbaum J (2003) The amyloidoses. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 2015–2025Google Scholar
  6. Drenth JP, van der Meer JW (2001) Hereditary Periodic Fever. N Engl J Med 345:1748PubMedGoogle Scholar
  7. Drenth JPH, Endres R, Belohradsky BH, Meer JWM van der (1996) Das Hyper-IgD-Syndrom. Dtsch Med Wochenschr 121:1299–1300PubMedGoogle Scholar
  8. Felson DT, Cummings SR (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594–2598PubMedGoogle Scholar
  9. Forgács SS (2003) Acromegaly. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 1967–1972Google Scholar
  10. Gao JK, Goronzy JJ, Weyand CM (1990) Ten-year follow-up of a patient with multicentric reticulohistiocylosis associated with myopathy. Scand J Rheumatol 19:437–441PubMedGoogle Scholar
  11. Görg C, Görg K, Havemann K (1985) Histiocytosis X. Dtsch Med Wochenschr 110:1902–1906PubMedGoogle Scholar
  12. Golding DN (1993) Rheumatism and the thyroid. J R Soc Med 86:130–132PubMedGoogle Scholar
  13. Handel ML, Simons L (2000) Rheumatic manifestations of hyperlipidaemia. Baillieres Best Pract Res Clin Rheumatol 14:595–598PubMedGoogle Scholar
  14. Kahn MF (2006) Does hormone replacement therapy discontinuation cause musculoskeletal pain? Joint Bone Spine 73:488–489PubMedGoogle Scholar
  15. Kastner DL (2003) Hereditary periodic fevers. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 1717–1734Google Scholar
  16. Keller JM, Macaulay W, Nercessian OA, Jaffe IA (2005) New developments in ochronosis: review of the literature. Rheumatol Int 25:81–85PubMedGoogle Scholar
  17. Kleerekoper M, Igwe R (2003) Hyperparathyroidismus. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 2129–2132Google Scholar
  18. Lanzer G (1981) Das Komplementsystem. Lab Med 5:1575Google Scholar
  19. Larkin JG (1992) Miscellaneous neurologic, cardiac, pulmonary and metabolic disorders with rheumatic manifestations. Curr Opin Rheumatol 24:106–112Google Scholar
  20. Lee AH, Levinson AI, Schumacher HR jr (1993) Hypogammaglobulinämie and rheumatic diseases. Semin Arthitis Rheum 22:252–264Google Scholar
  21. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedGoogle Scholar
  22. Martinez-Lavin M, Vargas A, Rivera-Viñas M (2008) Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation. Curr Opin Rheumatol 20:88–91PubMedGoogle Scholar
  23. Manger B, Mengel E, Schaefer RM (2007) Rheumatologic aspects of lysosomal storage diseases. Clin Rheumatol 26:335–341PubMedGoogle Scholar
  24. Menerey KA, Eider W, Brener GJ, Braunstein EM, Schumacher HR, Tox JH (1988) The arthropathy of Wilson’s disease. Clinical and pathologic features. J Rheumatol 15:331–337PubMedGoogle Scholar
  25. Michels H, Mengel E (2008) Lysosomal storage diseases as differential diagnoses to rheumatic disorders. Curr Opin Rheumatol 20:76–81PubMedGoogle Scholar
  26. Molloy ES, McCarthy GM (2003) Hydroxyapatite deposition disease of the joint. Curr Rheumatol Rep 5:215–221PubMedGoogle Scholar
  27. Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, Rosen F, Seger R, Geha R, for the International Union of Immunological Societies (2006) Primary immunodeficiency diseases classification committee. Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117:88–896Google Scholar
  28. Pickering MC, Walport MJ (2003) The complement system. In: Hochberg et al. (eds) Rheumatology, 3rd ed, vol 1, Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 1323–1335Google Scholar
  29. Rau R (2004) Arthropathien bei endokrinen Störungen. Z Rheumatol 63:30–42PubMedGoogle Scholar
  30. Rihl M, Kellner H (2004) Die Arthropathie der heriditären Hämochromatose. Z Rheumatol 63:22–29PubMedGoogle Scholar
  31. Schifferli JA, Peters DK (1983) Complement, the immunecomplex lattice and the pathophysiology of complement-deficiency syndroms. Lancet II:957–959Google Scholar
  32. Schneider P, Schneider I (2004) Calciumpyrophosphatdihydrat (CPPD)-Kristallarthropathie. Z Rheumatol 63:10–21PubMedGoogle Scholar
  33. Schnorpfeil F, Rösler N, Huffmann G (1996) Myopathien bei endokrinen Erkrankungen und Kortisontherapie. Inform Arzt 17:375–380Google Scholar
  34. Sheldon PJ, Forrester DM (2003) Imaging of amyloid arthropathy. Semin Musculoskelet Radiol 7:195–203PubMedGoogle Scholar
  35. Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J (2005) Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine 72:503–514PubMedGoogle Scholar
  36. Stankovic K, Grateau G (2007) Auto inflammatory syndromes: Diagnosis and treatment. Joint Bone Spine 74:544–550PubMedGoogle Scholar
  37. Tajirian AL, Malik MK, Robinson-Bostom L, Lally EV (2006) Multicentric reticulohistiocytosis. Clin Dermatol 24:486–492PubMedGoogle Scholar
  38. Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585–593PubMedGoogle Scholar
  39. Willman CL, Lambert B, Griffith BB, Favara BE et al (1994), Langerhans’-Cell Histiocytosis (Histiocytosis X)-A Clonal Proliferative Disease. N Engl J Med 3:164–160Google Scholar
  40. Wortmann RL (2003) Inflammatory and metabolic myopathies. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 1563–1571Google Scholar
  41. Zuber M (2006) Steifigkeit der Finger und Faustschlussdefizit bei einem 58-jährigen Patienten mit Diabetes mellitus. Med Klin 101:255–256Google Scholar

Literatur zu 9.1.6

  1. Arman MJ (1990) Gelenkbeteiligung bei Hämoglobinopathien. Akt Rheumatol 15:17–22Google Scholar
  2. Aviña-Zubieta JA, Galindo-Rodriguez G, Lavalle C (1998) Rheumatic manifestations of hematologic disorders. Curr Opin Rheumatol 10:86–90PubMedGoogle Scholar
  3. Castro M, Conn DL, Su WPD, Garton JP (1991) Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 18:721–727PubMedGoogle Scholar
  4. Cordner S (2003) Joint and bone lesions in hemoglobinopathies. In: Hochberg et al. (eds) Rheumatology, 3rd ed, vol 1, Mosby Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 1999–2004Google Scholar
  5. Ehrenfeld M, Gur H, Shoenfeld Y (1999) Rheumatologic features of hematologic disorders. Curr Opin Rheumatol 11:62–67PubMedGoogle Scholar
  6. Euler HH, Herr AH, Löffler H (1991) Arthropathien bei hämatologischen Systemerkrankungen. Akt Rheumatol 16:39–43Google Scholar
  7. Huang KY, Lin RM, Yan JJ, Lin CJ (2007) Langerhans cell histiocytosis as a possible differential diagnosis of painful scoliosis. Joint Bone Spine 74:396–399PubMedGoogle Scholar
  8. Jean-Baptiste G, De Ceulaer K (2000) Osteoarticular disorders of haematological origin. Baillieres Best Pract Res Clin Rheumatol 14:307–323PubMedGoogle Scholar
  9. Kinlen LJ (1992) Malignancy in autoimmune diseases. J Autoimmun 5(Suppl A):363–371PubMedGoogle Scholar
  10. Macfarlane JD, Kroon HM, Caekebeke-Peerlink KMJ (1989) Arthropathy in von Willibrand’s disease. Clin Rheumatol 8:98–102PubMedGoogle Scholar
  11. Martin-Santos JM, Mulero J, Andréu JL, Villa LF de, Bernaldo de Quiros L, Moguera E (1988) Arthritis in idiopathic hypereosinophilic syndrome. Arthritis Rheum 31:120–125Google Scholar
  12. Menon S, Isenberg DA (1995) Rheumatological manifestations of haematological diseases. Ann Rheum Dis 54:787–795PubMedGoogle Scholar
  13. Pessler F, Paessler ME, Lambert M, Morgan Dewitt E, Sherry DD (2007) Polyarthritis in a child with Rosai-Dorfman disease. Clin Exp Rheumatol 25:645–648Google Scholar
  14. Reuss-Borst MA (2005) Rheuma und hämato-onkologische Erkrankungen. Z Rheumatol 64:3–11PubMedGoogle Scholar
  15. Schapira D, Kerner H, Scharf Y (1993) Erosive arthritis in a patient with mycosis fungoides. J R Soc Med 86:176–177PubMedGoogle Scholar
  16. Tsochatzis E, Vassilopoulos D, Deutsch M, Filiotou A, Tasidou A, Archimandritis AJ (2005) Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review. J Clin Rheumatol 11:326–328PubMedGoogle Scholar
  17. York JR (2003) Hemophilia. In: Hochberg et al. (ed) Rheumatology, 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 1991–1998Google Scholar

Literatur zu 9.1.7

  1. Braun MG, Polnau U, Becker-Capeller D (2002) 35-Jahre-alter Patient mit Oligoarthritis, Bakteriämie und Aorteninsuffiziens. Internist 43:883–886PubMedGoogle Scholar
  2. Lange U, Strunk J (2005) Kardiovaskuläre Manifestationen bei entzündlich-rheumatischen Erkrankungen. Z Rheumatol 64:12–17PubMedGoogle Scholar
  3. Larkin JG (1992) Miscellaneous neurologic, cardiac, pulmonary and metabolic disorders with rheumatic manifestations. Curr Opin Rheumatol 14:106–112Google Scholar
  4. Molloy ES (2007) Challenges of Differential Diagnosis: The Pulmonary-Renal Syndrome and Aortitis. Int J Adv Rheumatol 4:120–127Google Scholar
  5. Slobodin G, Naschitz JE, Zuckerman E, Zisman D, Rozenbaum M, Boulman N, Rosner I (2006) Aortic involvement in rheumatic diseases. Clin Exp Rheumatol 24(2 Suppl 41):S41–47Google Scholar
  6. Specker C (2007) Das Herz bei rheumatologischen Erkrankungen. Internist 48:284–289PubMedGoogle Scholar
  7. Thomas P, Allal J, Bontoux D, Rossi F et al. (1984) Rheumatological manifestations of infective endocarditis. Ann Rheum Dis 43:716–720PubMedGoogle Scholar
  8. Wagener P, Schulter D, Wagenbreth J, Heublein B (1991) Rheumatische Manifestationen bei Patienten nach einer Herztransplantation. Akt Rheumatol 16:48–51Google Scholar
  9. Woolfe AD (1990) Unusual arthropathies. Med Inf (London) 75:3136–3139Google Scholar

Literatur zu 9.1.8

  1. Du Bois RM, Wells AU (2003) The lung in rheumatic diseases. In: Hochberg et al. (ed) Rheumatology, 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 315–323Google Scholar
  2. Johnson S, Knox AJ (1994) Arthropathy in cystic fibrosis. Respir Med 88:567–570PubMedGoogle Scholar
  3. Hauber HP, Zabel P (2007) Lunge und Autoimmerkrankungen — Klinik und Diagnostik. Dtsch Med Wochenschr 132:1633–1638PubMedGoogle Scholar
  4. Molloy ES (2007) Challenges of differential diagnosis: the pulmonaryrenal syndrome and aortitis. Int J Adv Rheumatol 4:120–127Google Scholar
  5. Merkel PA (1999) Rheumatic disease and cystic fibrosis. Arthr Rheum 42:1563–1571Google Scholar
  6. Schlapbach P, Imhof V (1987) Lungenmanifestationen bei chronischer Polyarthritis. Dtsch Med Wochenschr 112:1869–1871PubMedGoogle Scholar

Literatur zu 9.1.9

  1. Abi Karam G, Awada H, Nasr F, Uthman I (2003) Ileal pouchitis and arthritis. Semin Arthritis Rheum 33:215Google Scholar
  2. Balbir-Gurman A, Schapira D, Nahir M (2001) Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis. Semin Arthritis Rheum 30:242–248PubMedGoogle Scholar
  3. Bansky G (1986) Extraintestinale Manifestationen bei chronisch entzündlichen Darmerkrankungen. Schweiz Rundsch Med Prax 75:303–310PubMedGoogle Scholar
  4. Braun J, Sieper J (1999) Rheumatologic manifestations of gastrointestinal disorders. Curr Opin Rheumatol 11:68–74PubMedGoogle Scholar
  5. Bolten WW (1996) Rheuma und Magen-Darm-Trakt. Dtsch Arztebl 93:380–384Google Scholar
  6. Botzenhardt M (1987) Morbus Behçet Morbus Whipple und Arthritiden nach gastrointestinalem Bypass-Operationen. Z Rheumatol 46 (Suppl 1):22–25PubMedGoogle Scholar
  7. Clarke J, Weiner SR, Bassel LW, Ütsinger PD (1987) Bypass disease. Clin Exp Rheumatol 5:275–287PubMedGoogle Scholar
  8. Guerre-Schmidt AR, Pelletier F, Carbonnel F, Humbert P, Aubin F (2006) Dermatosis-arthritis syndrome associated with Crohn’s disease in a teenager. Rev Med Interne 27:874–877PubMedGoogle Scholar
  9. Hernandez L, Green PH (2006) Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 8:383–389PubMedGoogle Scholar
  10. Lee SK, Green PH (2006) Celiac sprue (the great modern-day imposter). Curr Opin Rheumatol 18:101–107PubMedGoogle Scholar
  11. Mielants H, Veys EM (2003) Gastrointestinal tract and rheumatic disease. In: Hochberg et al. (ed) Rheumatology, 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 325–333Google Scholar
  12. Narváez J, Montala N, Busquets-Pérez N, Nolla JM, Valverde J (2006) Collagenous colitis and spondylarthropathy. Arthritis Rheum 55:507–512PubMedGoogle Scholar
  13. Rabast U (2004) Bakterielle Fehlbesiedelung des Dünndarms-Blind loop syndrom. Aktuel Ernaehr Med 29:153–158Google Scholar
  14. Rau R (2004) Arthropathien bei endokrinen Störungen. Z Rheumatol 63:30–42PubMedGoogle Scholar
  15. Rogler G, Schölmerich J (2004) Extraintestinale Manifestationen bei chronisch-entzündlichen Darmerkrankungen. Med Klinik 99:123–130Google Scholar
  16. Schneider T, Zeitz M (2003) Krankheits-und Immunphänomene bei Morbus Whipple. Differenzialdiagnose zu rheumatoiden Erkrankungen. Internist 44:184–190PubMedGoogle Scholar
  17. Slater GH, Kerlin P, Georghiou PR, Fielding GA (2004) Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obesity Surgery 14:133–135PubMedGoogle Scholar

Literatur zu 9.1.10

  1. Botton E, Saraux A, Laselve H, Jousse S, Le Goff P (2003) Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine 70:327–335PubMedGoogle Scholar
  2. Gibson TJ, Schumacher HR, Pasqual E, Brighton C (1975) Arthropathy, skin and bone lesions in pancreatic disease. Z Rheumatol 2:7Google Scholar
  3. Kaurich T (2008) Drug-induced acute pancreatitis. Proc (Bayl Univ Med Cent) 21:77–81Google Scholar
  4. Ramos-Remus C, Bahlas S, Vaca-Morales O (1997) Rheumatic features of gastrointestinal tract, hepatic, and pancreatic diseases. Curr Opin Rheumatol 9:56–61PubMedGoogle Scholar
  5. Reynolds JC, Inman RD, Kimberly RP, Chuong JH, Kovaos JE, Wlash MB (1982) Acute pancreatitis in SLE: report of twenty cases and a review of the literature. Medicine 61:25–32PubMedGoogle Scholar
  6. Shbeeb MI, Duffy J, Bjornsson J, Ashby AM, Matteson EL (1996) Subcutaneous fat necrosis and polyarthritis associated with pancreatic disease. Arthritis Rheum 39:1922–1925PubMedGoogle Scholar
  7. Simkin PA, Brunzell JD, Wisner D et al. (1983) Free fatty acids in the pancreatic arthritis syndrome. Arthritis Rheum 26:127–132PubMedGoogle Scholar
  8. Waterlot Y, Perez A, Cauchie P (1984) Febrile polyarthritis and cutaneous nodules. An unusual presentation of a pancreatitis. Clin Rheumatol 3:521–524PubMedGoogle Scholar
  9. Zandieh I, Byrne MF (2007) Autoimmune pancreatitis: a review. World J Gastroenterol 13:6327–6332PubMedGoogle Scholar

Literatur zu 9.1.11

  1. Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129PubMedGoogle Scholar
  2. Bittencourt PL, Farias AQ, Porta G, Cançado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ (2008) Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol 42:300–305PubMedGoogle Scholar
  3. Czaja AJ (2007) Autoimmune liver disease and rheumatic manifestations. Curr Opin Rheumatol 19:74–80PubMedGoogle Scholar
  4. Dreher R (1987) Arthritiden bei Leber-und Pankreaserkrankungen. Z Rheumatol 46 (Suppl): 61–64PubMedGoogle Scholar
  5. Fitz JG, Petri M, Hellmann D (1987) Chronic active hepatitis presenting with rheumatoid nodules and arthritis. J Rheumatol 14:595–598PubMedGoogle Scholar
  6. Hartmann U, Schmitt S, Reuss-Borst M (2008) Leberwerterhöhung bei rheumatoider Arthritis. Differenzialdiagnostische Überlegungen an einem Fallbeispiel. Z Rheumatol Apr 18 (Epub ahead of print)Google Scholar
  7. Herr W, Lohse AW, Spahn TW et al. (1996) Nodular nonsuppurative panniculitis in association with primary bilary cirrhosis and Hashimoto’s thyreoiditis. Z Rheumatol 55:122–126PubMedGoogle Scholar
  8. Ioachimescu OC, Stoller JK (2005) A review of alpha-1 antitrypsin deficiency. COPD 2:263–275PubMedGoogle Scholar
  9. Lindström FD, Skogh T, Lundström IM (2002) Alpha(1) Antitrypsin deficiency in a patient with systemic vasculitis and primary Sjögren’s syndrome. Ann Rheum Dis 61:945–946PubMedGoogle Scholar
  10. Ozorio G, McGarity B, Bak H, Jordan AS, Lau H, Marshall C (2007) Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust 187:524–526PubMedGoogle Scholar
  11. Schiemann U, Kellner H (2002) Gastrointestinale Nebenwirkungen der Therapie rheumatischer Erkrankungen. Z Gastroenterol 40:937–943PubMedGoogle Scholar
  12. Segal AM, Mackenzie AH (1982) Hyperthrophic arthropathy: a 10-year retrospective analysis. Seminars Arthritis Rheum 12:220–232Google Scholar
  13. Tobon G, Cañas C, Jaller JJ, Restrepo JC, Anaya JM (2007) Serious liver disease induced by infliximab. Clin Rheumatol 26:578–581PubMedGoogle Scholar
  14. Youssef WI, Tavill AS (2002) Connective tissue diseases and the liver. J Clin Gastroenterol 35:345–349PubMedGoogle Scholar

Literatur zu 9.1.12

  1. Bardin T, Kuntz D (2003) Dialysis arthropathy. In: Hochberg et al. (eds) Rheumatology, 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 1983–1986Google Scholar
  2. Chou C-T, Wasserstein A, Schumacher HR jr, Fernandez P (1985) Musculoskeletal manifestations in hemodialysis patients. Z Rheumatol 12:1149–1153Google Scholar
  3. Clive DM (2000) Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 11:974–979PubMedGoogle Scholar
  4. Daram SR, Cortese CM, Bastani B (2005) Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46:754–759PubMedGoogle Scholar
  5. Heinrich M, Uder M (2007) Nephrogene systemische Fibrose nach Anwendung gadoliniumhaltiger Kontrastmittel — ein Statuspapier zum aktuellen Stand des Wissens. Fortschr Röntgenstr 179:613–617Google Scholar
  6. Karie S, Launay-Vacher V, Izzedine H, Deray G (2005) Drug-induced nephrotoxicity: bibliography from January 2003 to December 2004. Nephrol Ther 1:285–295PubMedGoogle Scholar
  7. Kart-Köseoglu H, Yücel AE, Isiklar I, Türker I, Akçali Z, Haberal M (2003) Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy. Rheumatol Int 23:159–162PubMedGoogle Scholar
  8. Kay J, Bardin T (2000) Osteo articular disorders of renal origin: diseaserelated and iatrogenic. Baillieres Best Pract Res Clin Rheumatol 14:285–305PubMedGoogle Scholar
  9. Schwarting A, Märker-Hermann E (2005) Renale Manifestationen rheumatischer Erkrankungen. Z Rheumatol 64:18–25PubMedGoogle Scholar
  10. Stuby U, Zazgornik J (2001) Klinik der renalen Osteodystrophie. Journal für Mineralstoffwechsel 8:7–8Google Scholar

Literatur zu 9.1.13

  1. Barnard J, Newman LS (2001) Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol 13:84–91PubMedGoogle Scholar
  2. Judson MA (2007) Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 28:83–101PubMedGoogle Scholar
  3. Müller W, Wurm K (1989) Rheumatische Syndrome bei der Sarkoidose. Akt Rheumatol 5:39–52Google Scholar
  4. Pettersson T (1997) Rheumatic features of sarcoidosis. Curr Opin Rheumatol 9:62–67PubMedGoogle Scholar
  5. Wurm K (1989) Sarkoidose. Dtsch Krankenpfl Z 11:758–762Google Scholar

Literatur zu 9.2

  1. Beighton PH, Grahame R (1999) Bird HA. Hypermobility of joints. 3rd ed. Springer, Berlin Heidelberg New YorkGoogle Scholar
  2. Graham R (1996) Das Hypermobilitätssyndrom. Rheumatol Eur 25:124–127Google Scholar
  3. Manger B, Menge E, Schaefer R, Haase C, Seidel J, Michels H (2006) M. Gaucher, M. Fabry und Mukopolysaccharidose Typ I—Wie kann der Rheumatologe diese Patienten erkennen. Z Rheumatol 65:32–43PubMedGoogle Scholar
  4. Marini JC (2003) Heritable connective tissue disorders. In: Hochberg et al. (ed) Rheumatology 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney Toronto, p 2161–2169Google Scholar
  5. Pastores GM, Meere PA (2005) Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I). Curr Opin Rheumatol 17:70–78PubMedGoogle Scholar
  6. Ringe JD (2007) Die Osteoporose des Mannes. Arthritis+Rheuma 27:323–327Google Scholar
  7. Royce P, Steinmann B (eds) (1993) Connective tissue and its heritable disorders. Molecular, genetic and medical aspects. Wiley Liss, New York Chichester BrisbaneGoogle Scholar
  8. Schilling F (2007) Das familiäre systematisierte Hypermobilitätssyndrom bei generalisierter Bindgewebsschwäche. Akt Rheumatol 32:341–334Google Scholar
  9. Skoumal M, Haberhauer G, Mayr H (2004) Begleiterkrankungen bei primärer Gelenkhypermobilität. Med Klin 99:585–590Google Scholar

Literatur zu 9.3

  1. Abu-Id MH, Açil Y, Gottschalk J, Kreusch T (2006) Bisphosphonatassoziierte Osteonektrose des Kiefers. Mund Kiefer Gesichtschir 10:73–81PubMedGoogle Scholar
  2. Benning K, Müller-Ladner U, Rauh G, Lang B (1993) Die chronisch rezidivierende Polychondritis. Z Rheumatol 53:142–149Google Scholar
  3. Devogelaer JP, Nagant de Deuxchaisne C (2003) Paget’s disease of bone. In: Hochberg et al. (ed) Rheumatology 3rd Edition, vol 1, Mosby, Edinburgh, London, New York, Philadelphia, St. Louis, Sydney, Toronto, p 2139–2147Google Scholar
  4. Elkayam O, Paran D, Flusser G, Wigler I, Yaron M, Caspi D (2000) Insufficiency fractures in rheumatic patients: Misdiagnosis and underlying characteristics. Clin Exp Rheumatology 18:369–374Google Scholar
  5. Freyschmidt J, Ostertag H (1988) Knochentumoren Springer, Berlin Heidelberg New YorkGoogle Scholar
  6. Hardegger F, Simpson LA, Segmueller G (1985) The syndrome of idiopathic osteolysis. J Bone Joint Surg Br 67:89–93Google Scholar
  7. Kech E, Hehrmann A (1987) Primary hyperparathyreoidismus. In: Kuhlencordt F et al. (eds) Generalized bone disease. Springer, Berlin Heidelberg New YorkGoogle Scholar
  8. Lehnisch R (1996) Fracture de fatigue. Inform Arzt 17:805–806Google Scholar
  9. Mangat P, Jawad AS (2005) Case number 32: Thiemann’s disease. Ann Rheum Dis 64:11–12PubMedGoogle Scholar
  10. Ruggiero SL, Woo SB (2008) Biophosphonate-related osteonecrosis of the jaws. Dental Clin of North America 52:111–128Google Scholar
  11. Schilling F (1997) Die chronisch rekurrierende multifokale Osteomyelitis (CRMO). Kurze Literaturübersicht, Nosologie, diagnostische Kriterien und rheumatologische Differentialdiagnose. Akt Rheumatol 22:41–46Google Scholar
  12. Seibel MJ, Strake H (1997) Metabolische Osteopathien. Schattauer, Stuttgart New YorkGoogle Scholar
  13. Vogelhuber M, Georgi J, Landthaler M, Menninger H (1996) Die idiopathische Osteolyse (Gorham-Stout) mit Gelenkbeteiligung? Akt Rheumatol 21:21–26Google Scholar
  14. Zizic TM, Marcoux C, Hungerford DS, Stevens BM (1986) The early diagnosis of ischemic necrosis of bone. Arthritis Rheum 29:1177–1186PubMedGoogle Scholar

Literatur zu 9.4

  1. Benning K, Müller-Ladner U, Rauh G, Lang B (1993) Die chronisch rezidivierende Polychondritis. Z Rheumatol 52:142–149PubMedGoogle Scholar
  2. Candia L, Cuellar ML, Marlowe SM, Marquez J, Iglesias A, Espinoza LR (2006) Charcot-like arthropathy: A newly-recognized subset of psoriatic arthritis. Clin Exp Rheumatol 24:172–175PubMedGoogle Scholar
  3. Castro M, Conn DL, Su WPD, Garton JP (1991) Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 18:721–727PubMedGoogle Scholar
  4. Chakravarty E, Genovese MC (2003) Rheumatic syndromes associated with malignancy. Curr Opin Rheumatol 15:35–43PubMedGoogle Scholar
  5. Fam AG (2000) Paraneoplastic rheumatic syndromes. Clin Rheumatol 14:515–533Google Scholar
  6. Hofmann S, Kramer J, Breitenseher M, Pietsch M, Aigner N (2006) Knochenmarködem im Kniegelenk. Differenzialdiagnostik und therapeutische Möglichkeiten. Orthopäde 35:463–475PubMedGoogle Scholar
  7. Honorat J, Antoine JC (2007) Paraneoplastic neurological syndromes. Orphanet J of Rare Dis 2:22–29Google Scholar
  8. Naschitz JE, Rosner J, Rozenbaum M, Elias N, Yeshuran D (1995) Cancer-associated rheumatic disorders: Clues in occult neoplasia. Semin Arthritis Rheum 24:231–241Google Scholar
  9. Naschitz JE, Rosner J, Rozenbaum M, Zuckerman E, Yeshurun D (1999) Rheumatic syndromes: Clues to occult neoplasia. Semin Arthritis Rheum 29:43–55PubMedGoogle Scholar
  10. Mohr W (1995) Pigmentierte villonoduläre Synovitis. Rheumatol Eur 24:164–165Google Scholar
  11. Pfitzenmeyer P, Bielefeld P, Tavernier C et al. (1992) Current aspects of paraneoplastic acute polyarthritis. Rev Med Intern 13:195–199Google Scholar
  12. Provedano JB, Corteguera M, Garcia Lopez A et al. (1990) Articular metastasis. Presentation of three cases and review of the literature. Rev Esp Rematol 17:100–103Google Scholar
  13. Samanta A, Hilton D, Roy S (1990) Peripheral neuropathy, polymyalgia and arthralgia: a paraneoplastic syndrome associated with myeloma. Clin Rheumatol 9:246–248PubMedGoogle Scholar
  14. Sanchez-Guerrero J, Gutierrez-Mrena SV, Daller A (1990) Vasculitis as a paraneoplastic syndrome: report of 11 cases and review of the literature. J Rheumatol 17:1458–1462PubMedGoogle Scholar
  15. Segal AM, Mackenzie AH (1982) Hypertrophic osteoarthropathy: A 10-year retrospective analysis. Arthritis Rheum 12:220–233Google Scholar
  16. Van Besien K, Tricol G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 40:47–50PubMedGoogle Scholar

Literatur zu 9.5

  1. Bamborschke S, Hojer C (1992) Polyneuropathie und Polyneuritis: Klinik, Diagnostik und Therapie. Med Klin 87:522–526Google Scholar
  2. Corbo M, Nemni R, Iannaccone S, Quattrini A, Lodi M, Praderio L, Comola M, Lorenzetti I, Comi G, Canal N (1993) Peripheral neuropathy in scleroderma. Clin Neuropathol 12:63–67PubMedGoogle Scholar
  3. Crinquette C, de Seze J, Maurage CA, Launay D, Ferriby D, Delalande S, Hachulla E, Stojkovic T, Vermersch P (2007) Polymyosite et atteinte de nerfs crâniens. Rev Neurol 163:1075–1081PubMedGoogle Scholar
  4. Dury P, Dirheimer Y, Pattin S (1996) Algodystrophie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  5. Hasegarsu Y, Ninomiya M, Yamada Y, Hattori T (1996) Osteoarthropathy in congenital sensory neuropathy with anhidrosis. Clin Orthop 258:232–336Google Scholar
  6. Jubelt B, Drucker J (1993) Post-polio Syndrome: An update. Semin Neurol 13:283–289PubMedGoogle Scholar
  7. Mucha C (1987) Schulter-Hand-Syndrom, Algodystrophie (Sudeck-Syndrom). Therapiewoche 37:3978–3989Google Scholar
  8. Mumenthaler M, Stöhr M, Müller-Vahl H (2007) Läsionen peripherer Nerven und radikuläre Syndrome Thieme, StuttgartGoogle Scholar
  9. Nadeau SE (2002) Neurologic Manifestations of Connective Tissue Disease. Neurol Clin 20:151–178PubMedGoogle Scholar
  10. Newsom-Davis J (1995) The Hughlings Jackson Lecture: Autoimmunity and the nervous system. J R Soc Med 88:639p–643pPubMedGoogle Scholar
  11. Niederwieser G, Bonelli RM, Pongratz R, Neubauer M, Buchinger W, Kammerhuber F, Reisecker F, Kleinert R, Költringer P (2001) Cerebral vasculitis associated with Reiter’s syndrome. J Neurol 248:988–989PubMedGoogle Scholar
  12. Reimers CD, Ratzka P (2006) Diagnostik der Polyneuropathien: eine tabellarische Übersicht Z Rheumatol 31:6–15Google Scholar
  13. Russell LC, Latov N (2005) Central nervous system manifestations of rheumatologic diseases. Curr Opin Rheumatol 17:91–99Google Scholar
  14. Tyrrell PN, Davies AM, Evans N (1994) Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis 53:714–717PubMedGoogle Scholar
  15. West SG, Emlen W, Wener M, Kotzin BL (1995) Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 335:1424–1430Google Scholar

Literatur zu 9.6

  1. Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (AMDP) (1997) Das AMDP-System. Göttingen: HogrefeGoogle Scholar
  2. Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J (2005) Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ 331(7521):884PubMedGoogle Scholar
  3. Büchi S, Sensky T, Sharpe L, Timberlake N (1998) Graphic representation of illness: A novel method of measuring patients’ perceptions of the impact of illness. Psychother Psychosom 67:222–225PubMedGoogle Scholar
  4. Büchi S, Buddeberg C, Klaghofer R et al. (2002) Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) — a brief method to assess suffering. Psychother Psychosom 71(6):333–341PubMedCrossRefGoogle Scholar
  5. Büchi S, Sensky T (1999) PRISM-(Pictorial Representation of Illness and Self Measure)-a brief non-verbal measure of illness impact and therapeutic aid in psychosomatic medicine. Psychosomatics 40:314–320PubMedGoogle Scholar
  6. Büchi S, Villiger P, Kauer Y, Klaghofer R, Sensy T, Stoll T (2000) PRISM (Pictorial Representation of Illness and Self Measure) a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus. Lupus 9:368–373PubMedGoogle Scholar
  7. Cassel EJ (1982) The nature of suffering and the goals of medicine. NEJM 306:639–645PubMedGoogle Scholar
  8. Chapman RC, Gavrin J (1993) Suffering and its relation to pain. J Palliat Care 9:5–13PubMedGoogle Scholar
  9. Drew FL (1986) Suffering and autonomy. In: DeBellis R, Marcus E, Kutschner AH, Smith Torres C, Barrett V, Siegel ME (eds) Suffering-psychological and social aspects of loss, grief and care. New York London: Haworth Press: 19–24Google Scholar
  10. Egle UT, Hoffmann SO, Lehmann KA, Nix WA (2003) Handbuch chronischer Schmerzen. Schattauer, StuttgartGoogle Scholar
  11. Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166(15):1649–1654PubMedGoogle Scholar
  12. Katon W, Lin EHB, Kroenke K (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry 29(2):147–155PubMedGoogle Scholar
  13. Klagsburn SC (1994) Patient, family, and staff suffering. J Palliat Care 10:14–17Google Scholar
  14. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM (2006) Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124(1–2):117–125PubMedGoogle Scholar
  15. Waddel G (2004) The back pain revolution (2nd ed.) Churchill Livingstone, EdinburghGoogle Scholar
  16. Wittmann L, Sensky T, Maeder L, Michel BA, Stoll T, Büchi S (2008) Suffering and posttraumatic growth in patients with systemic lupus erythematosus (SLE)—a qualitative-quantitative case study. Psychosomatics (in press)Google Scholar

Literatur zu 9.7

  1. Blunt RJ, Porter JM (1981) Raynaud-Syndrome. Semin Arthritis Rheum 10:282PubMedGoogle Scholar
  2. Freyschmidt J, Freyschmidt G (1996) Haut-, Schleimhaut-und Skeletterkrankungen. Skubo-Diseases. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  3. Gebhardt M, Wollina U (1995) Kutane Nebenwirkungen nichtsteroidaler Antiphlogistika (NSAID). Z Rheumatol 54:405–412PubMedGoogle Scholar
  4. González-Gay MA, Garcia-Porrúa C, Pujol RM, Salvarani C (2001) Erythema nodosum: a clinical approach. Clin Exp Rheumatol 19:365–368PubMedGoogle Scholar
  5. Hofmann C, Richter W, Hiller C, Burg G (1987) Urticaria-Vaskulitis. Z Rheumatol 46:233–236PubMedGoogle Scholar
  6. Knitzer RH, Needleman BW (1991) Muskuloskeletal syndromes associated with acne. Semin Arthritis Rheum 20:247–255PubMedGoogle Scholar
  7. McNeil DJ, Kinsella TD, Crawford A-M, Fritzler MJ (1987) The AHA syndrome: arthritis, hives and angiooedema. Rheumatol Intern 7:277–279Google Scholar
  8. Mensing H (1988) Akute febrile neutrophile Dermatose: Sweet-Syndrom. Med Klinik 83:48–51Google Scholar
  9. Mrowietz U, Kiene P, Quinkert U (1996) Rheumatoid neutrophile Dermatitis-eine seltene Dermatose bei Patienten mit aktiver rheumatoider Arthritis. Hautarzt 47:921–926PubMedGoogle Scholar
  10. Sontheimer RD, Provost TT (eds) (1995) Cutaneus manifestations of rheumatic diseases. Williams & Wilkins, BaltimoreGoogle Scholar
  11. Wohlrab J, Fischer M, Marsch WC (2001) Aktuelle Diagnostik des Sneddon-Syndroms. Dtsch Med Wochenschr 126:725–728PubMedGoogle Scholar
  12. Wright V (1987) Skin and arthritis. Clin Exp Rheumatol 5/S-1:75–79Google Scholar

Literatur zu 9.8

  1. Banares A, Jover JA, Fernándes-Gutiérrez B et al. (1997) Patterns of uveitis as a guide in making rheumatologic and immunologic diagnosis. Arthritis Rheum 40:358–370PubMedGoogle Scholar
  2. Bortoli R, Santiago M (2007) Chloroquine ototoxicity. Clin Rheumatol 26:1809–1810PubMedGoogle Scholar
  3. Greiner K, Forrester J (2003) The eye and rheumatic disease. In: Hochberg et al. (eds) Rheumatology, 3rd ed, vol 1. Mosby, Edinburgh London New York Philadelphia St. Louis Sydney TorontoGoogle Scholar
  4. Hamideh F, Prete PE (2001) Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 30:217–241PubMedGoogle Scholar
  5. Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT (2004) Earnose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 22:485–494PubMedGoogle Scholar
  6. Roland JT (2000) Autoimmune inner ear disease. Current Rheumatology Reports 2:171–174PubMedGoogle Scholar
  7. Schwemmle C, Ptok M (2007) Bamboo nodes als Ursache von Dysphonien bei Autoimmunkrankheiten. HNO 55:564–568PubMedGoogle Scholar
  8. Wecker H, Laubert A (2004) Reversible Hörminderung bei akuter Salizylatintoxikation. HNO 52:347–351PubMedGoogle Scholar
  9. Voulgari PV, Papazisi D, Bai M, Zagorianakou P, Assimakopoulos D, Drosos AA (2005) Laryngeal involvement in rheumatoid arthritis. Rheumatol Int 25:321–325PubMedGoogle Scholar
  10. Zierhut M, Wohlrab TH-M (1997) Immunpathologische Erkrankungen des Auges. Dtsch Ärztebl 94:1429–1433Google Scholar

Literatur zu 9.9

  1. Huemer C, Huemer M (2006) Genetische Fiebersyndrome. Z Rheumatol 65:595–603PubMedGoogle Scholar
  2. Huppertz H-I (2006) Differenzial diagnose des Fiebers unklarer, Genese. Z Rheumatol 65:604–609PubMedGoogle Scholar
  3. Langer HE, Zeidler H (1988) Fieber bei rheumatischen Erkrankungen — Ursachenspektrum und diagnostische Leitlinien. Rheumatologie 47:413–424Google Scholar
  4. Langer HE, Zeidler H (1988) Unklares Fieber als differentialdiagnostische Herausforderung in der Rheumatologie. Akt Rheumatol 13:202–213Google Scholar
  5. Revaz S, Dudler J, Kai-Lik So A (2006) Fever and musculoskeletal symptoms in an adult: differential diagnosis and management. Best Pract Res Clin Rheumatol 20:641–651PubMedGoogle Scholar
  6. Soubrier M (2008) Schnitzler syndrome. Joint Bone Spine 75:263–266PubMedGoogle Scholar

Literatur zu 9.10

  1. Becker W, Krahl H (1978) Die Tendopathien. Grundlagen, Klinik, Therapie. Thieme, StuttgartGoogle Scholar
  2. Hazleman B, Riley G, Speed C (2004) Soft tissue rheumatology Oxford: Oxford Medical PublicationsGoogle Scholar

Literatur zu 9.11

  1. Langer HE, Mahrenholtz M, Zeidler H (1990) Rheumatologische Notfallsituationen. Wien Med Wochenschr 140:351–356PubMedGoogle Scholar
  2. Mandell BF (1994) Acute rheumatic and immunologic diseases. Marcel-Dekker, New YorkGoogle Scholar
  3. Schiavon F (2003) Transientjoint effusion: a forgotten side effect of high dose corticosteroid treatment. Ann Rheum Dis 62:491–492PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2009

Personalised recommendations